UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
 
FORM 8-A
______________________
 
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
______________________
 
THE DOW CHEMICAL COMPANY
(Exact Name of Registrant as Specified in its Charter)
______________________
Delaware
38-1285128
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
   
2211 H.H. Dow Way
Midland, Michigan 48674
(989) 636-1000
(Address of principal executive offices and zip code)
   
Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class
to be so registered
  
Name of each exchange on
which each class is to be registered
4.625% Notes due October 1, 2044
  
The New York Stock Exchange
 
______________________
 
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ☒
 
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ☐
 
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
 
Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-186728
 
Securities to be registered pursuant to Section 12(g) of the Act: None.
 


INFORMATION REQUIRED IN REGISTRATION STATEMENT
 
Item 1.
Description of Registrant’s Securities to be Registered.
 
The class of securities to be registered hereby is the $500,000,000 aggregate principal amount of 4.625% Notes due October 1, 2044 (the “Notes”), of The Dow Chemical Company, a Delaware corporation (the “Registrant”).
 
The description of the Notes is set forth under the captions “Prospectus Supplement Summary” and “Description of the Notes” in the Prospectus Supplement dated September 9, 2014 (the “Prospectus Supplement”) to the Prospectus dated February 19, 2013 (the “Prospectus”) forming part of its Registration Statement on Form S-3ASR (File No. 333-186728) filed with the Securities and Exchange Commission (the “Commission”) on February 19, 2013, under the Securities Act of 1933, as amended, which description is incorporated herein by reference.
 
Item 2.
Exhibits.
 
Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The New York Stock Exchange and the securities registered hereby are not being registered pursuant to Section 12(g) of Securities Exchange Act of 1934, as amended.
 



2

SIGNATURE
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
 
 
The Dow Chemical Company
   
     

By:
  /s/ Ronald C. Edmonds
 
Name:
Ronald C. Edmonds
  Title:
Controller and Vice President of Controllers and Tax
 
 Date: May 3, 2019
 




3